Presenter: E. Rutgers
PROF DR RUTGERS (1955) is a Surgical Oncologist at the Netherlands Cancer Institute in Amsterdam, Netherlands, Head of the Department of Surgery and Chair of the Institutes Breast Cancer Working Group. After earning a medical degree for the State University of Utrecht in the Netherlands, he completed his residency training in internal medicine at Sint Antonius Ziekenhuis, Utrecht, and his general surgery training at the St. Joseph-Ziekenhuis in Eindhoven. Prof Rutgers is currently Secretary General of the EORTC, further fellow fellow of the Royal College of Surgeons (London & Glasgow); treasurer and past-chair of the European Organization for Research and Treatment of Cancer (EORTC) Breast Group; and chair of the National Dutch Working Group for the guidelines on screening, diagnosis, and treatment of breast cancer. He is a member of several societies including the European Society of Surgical Oncology, Society of Surgical Oncology (United States), American Society of Clinical Oncology (ASCO), and of the Executive Committee of the European Society of Mastology. He was Chair of the European Breast Cancer conference in Berlin April 2008.
Prof Rutgers’ main fields of interest is breast cancer, with emphasis on prognostic and predictive factors (micro-array techniques), risk management and prevention, and optimalisation of surgical procedures including neo-adjuvant chemotherapy, sentinel node procedure and immediate breast reconstruction. He is on the editorial board of the European Journal of Surgical Oncology and the author or coauthor of more than 250 articles, abstracts, and book chapters on different aspects of breast cancer. Prof. Rutgers is the principal investigator of the EORTC-AMAROS Trial (in sentinel node biopsy in breast cancer) and the EORTC MINDACT Trial, which is studying the value the 70-gene micro-array Mammaprint test in node negative and positive breast cancer.
|University:||Netherlands Cancer Institute|